Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
about
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugsIn vitro and in vivo models for the study of oral delivery of nanoparticlesIn vitro and in vivo trypanocidal activity of H2bdtc-loaded solid lipid nanoparticlesVitamin D3-Loaded Nanostructured Lipid Carriers as a Potential Approach for Fortifying Food Beverages; in Vitro and in Vivo Evaluation.A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs.Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer.Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia.Nanostructured lipid carriers improve skin permeation and chemical stability of idebenonePreparation, characterization, and in vivo pharmacokinetics of nanostructured lipid carriers loaded with oleanolic acid and gentiopicrin.Nanostructured lipid carriers: versatile oral delivery vehicle.A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization.Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.Statins therapy: a review on conventional and novel formulation approaches.Nanostructured lipid carriers system: recent advances in drug delivery.Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.Nanostructured lipid carriers and their current application in targeted drug delivery.Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia.Exploitation of pleiotropic actions of statins by using tumour-targeted delivery systems.Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation.Stability study of sodium colistimethate-loaded lipid nanoparticles.Self-nanoemulsifying drug delivery systems ameliorate the oral delivery of silymarin in rats with Roux-en-Y gastric bypass surgeryNanostructured lipid carriers (NLCs) versus solid lipid nanoparticles (SLNs) for topical delivery of meloxicam.Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution.Preparation and optimization of triptolide-loaded solid lipid nanoparticles for oral delivery with reduced gastric irritation.Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis.Conjugation of melanotransferrin antibody on solid lipid nanoparticles for mediating brain cancer malignancy.Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.Enhanced oral delivery of curcumin from N-trimethyl chitosan surface-modified solid lipid nanoparticles: pharmacokinetic and brain distribution evaluations.Alginate-gelatin formulation to modify lovastatin release profile from red yeast rice for hypercholesterolemia therapy.Suppression of Remodeling Behaviors with Arachidonic Acid Modification for Enhanced in vivo Antiatherogenic Efficacies of Lovastatin-loaded Discoidal Recombinant High Density Lipoprotein.Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.Glucosamine derivative modified nanostructured lipid carriers for targeted tumor deliveryNanotechnology as Emerging Tool for Enhancing Solubility of Poorly Water-Soluble DrugsCore – Shell pH-Responsive Poly(Vinylpyrrolidone)-Block-Poly(Ethylene Glycol)-Block-Poly(Methacrylic Acid) Coated Magnetic Nanoparticle as a Carrier for Delivery of Poorly Water-Soluble LovastatinCytotoxic Effect of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) on Liver Cancer Cell Integrated with Hepatitis B Genome, Hep3BNovel Caffeic Acid Nanocarrier: Production, Characterization, and Release Modeling
P2860
Q26774831-01E08F9E-DEC1-4F45-AF20-3731B19D104DQ26829514-6200EBED-A742-46B4-8139-CC34FBC70D06Q27304890-24B9B47E-8A55-42B4-8FB3-FA2BC0E2B365Q33664092-1FA9B182-37A3-46D2-B1E5-EB2DF3A4814BQ33837845-2107210C-B706-40FB-A722-5AD9A549A1C4Q34444568-F536A203-14EA-4A70-9C60-164349D19B64Q34733880-6F9F8533-4C54-43EB-85FA-539B6044D9F2Q34823319-8BF06D0B-48A4-4076-BF76-CACC84E80BEEQ34944497-DCB286ED-0AB9-4287-B8AC-FBE78B55802BQ35821878-2D100735-0942-41AD-B668-905B350DBE5AQ37134733-57A235FE-A94A-4818-9E33-DF9C9539C1E4Q37474497-4D56D01D-15A9-4539-ABBE-F4F0E290B976Q37527859-D9A79804-6224-48A7-8B95-483611719968Q37602960-FB616558-002B-424B-AD8B-69CAD4DE3C9FQ37896125-04C067AF-9E2B-4F7D-AF25-11BC21676268Q38038902-5B33A49F-6E67-41C1-B5E3-4AB27017A321Q38199540-708AC66C-D05E-4915-A0E7-627BEE72E3CCQ38210565-E83572DC-2361-419C-A048-3ED906779DCCQ38218145-4B7AE112-5914-4B1E-9DEE-49CE21A6217AQ38572098-8BED1BA7-F813-430E-B09A-F5490FD20ACEQ39453040-E246D263-3E2F-477A-A993-422946075B8AQ40523637-1D42D585-B4BE-4397-89DB-0727F627E6F1Q41969540-85D3F9A2-9C02-4BB8-AADA-CC01A39F0430Q43762449-27E6FD58-8063-41D5-9F8C-00E5FC85E6C9Q45887220-534DD1BA-887B-47B2-9B1C-61035AE3B827Q46936967-67A1B95A-482F-4999-AFDF-93AAF6459F9AQ47895384-C9D89E36-9320-4F62-92A5-BF676DC17DD5Q47931787-C66D0374-EADE-4802-BB9F-4F80F4EB7ADCQ48273811-F9316AF2-6976-4182-8E54-7BE9D6C3AD4EQ48626221-6472922A-1FC8-429C-9B83-B9094838C17EQ49853312-72D157F4-EBAB-4E69-B461-801146B147EEQ53479332-F3C03242-8D49-4B04-8044-F6EA548238ADQ53490135-851DF84C-0429-441E-8B88-8A5B2C76ABA6Q57273335-289050E1-8DF1-43BE-B50C-285A7FBF3C0EQ57343790-71E0A7A8-4714-4930-969F-C3FF03EA3D6FQ57351421-747787E8-09C5-4BFD-9940-DF1598C05893Q58773062-7EACDF92-ACED-4C16-AD19-7831D21AB0CCQ59018330-8EF5CFED-1437-4B26-AA14-B45EB9B0B5A4
P2860
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effects of lipophilic emulsifi ...... rization and pharmacokinetics.
@en
Effects of lipophilic emulsifi ...... rization and pharmacokinetics.
@nl
type
label
Effects of lipophilic emulsifi ...... rization and pharmacokinetics.
@en
Effects of lipophilic emulsifi ...... rization and pharmacokinetics.
@nl
prefLabel
Effects of lipophilic emulsifi ...... rization and pharmacokinetics.
@en
Effects of lipophilic emulsifi ...... rization and pharmacokinetics.
@nl
P2093
P1476
Effects of lipophilic emulsifi ...... rization and pharmacokinetics.
@en
P2093
Chih-Chieh Chen
Jia-You Fang
Tung-Hu Tsai
Zih-Rou Huang
P304
P356
10.1016/J.EJPB.2009.12.008
P407
P577
2010-01-07T00:00:00Z